Partial esters of (Di) chloromethanediphosphonic acid useful for treating disorders relating to the metabolism of calcium
AssigneeLeiras Oy
InventorsEsko Pohjala, Keikki Nupponen, Jouko Vepsalainen
Life of this patent
Estimating the term…
Abstract
Novel pharmaceutically active bisphosphonic acid derivatives of formula (I), in which R.sup.1, R.sup.2, R.sup.3 and R.sup.4 independently are C.sub.1 -C.sub.22 -alkyl, C.sub.2 -C.sub.22 -alkenyl, C.sub.2 -C.sub.22 -alkynyl, C.sub.3 -C.sub.10 -cycloalkyl, C.sub.3 -C.sub.10 -cycloalkenyl, aryl, aralkyl, silyl and hydrogen, and R.sup.4 is different from hydrogen, Q.sup.1 is hydrogen, fluorine, chlorine, bromine or iodine, and Q.sup.2 is chlorine, bromine or iodine, including the stereoisomers, such as the geometrical isomers and optically active isomers, of the compounds, as well as the pharmaceutically acceptable salts of the compounds. ##STR1##
Claims6
A compound comprising a bisphosphonic acid derivative of the formula I ##STR13## including the stereoisomers optically active isomers thereof, and including a pharmaceutically acceptable salt thereof, wherein
- R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are independently selected from the group consisting of C.sub.1 -C.sub.7 -alkyl, and hydrogen,
- at least one of the groups R.sup.1, R.sup.2, R.sup.3 and R.sup.4 is hydrogen,
- at least one of the groups R.sup.1, R.sup.2, R.sup.3 and R.sup.4 is different from hydrogen,
- Q.sup.1 is selected from the group consisting of hydrogen and chlorine, and
- Q.sup.2 is chlorine.
Dependencies are inferred from the claim text.